Englebert L Rowe

Title: Englebert L Rowe: Innovator in Pharmaceutical Suspensions

Introduction

Englebert L Rowe is a notable inventor based in Kalamazoo, MI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. His work has led to advancements that enhance the stability and effectiveness of medications.

Latest Patents

Englebert L Rowe holds a patent for "Aluminum ibuprofen pharmaceutical suspensions." This patent describes aluminum ibuprofen pharmaceutical liquid suspensions that exhibit improved resistance to dissolution rate reduction upon storage. The formulation includes aluminum ibuprofen, a suspending agent with a particle size below 50 microns, a water-soluble surface active agent, water, and preferably from 5 to 30 grams of sucrose per 100 ml of suspension or its sweetening equivalent.

Career Highlights

Rowe has dedicated his career to pharmaceutical innovation, working at The Upjohn Manufacturing Company. His expertise in drug formulation has contributed to the development of effective pharmaceutical products that meet the needs of patients.

Collaborations

Throughout his career, Englebert L Rowe has collaborated with talented individuals such as Susanne M Peck and Lois J Larion. These partnerships have fostered a creative environment that encourages the exchange of ideas and the advancement of pharmaceutical science.

Conclusion

Englebert L Rowe's contributions to the field of pharmaceuticals, particularly through his patent on aluminum ibuprofen suspensions, highlight his role as an innovator. His work continues to impact the industry positively, showcasing the importance of research and development in creating effective medications.